Skip to main content

Animations

MJFF Publications

1901 - 1910 of 9148 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2023
  • 2023
  • 2021
  • 2021
  • 2023
  • 2021
  • 2023
  • 2021
  • Summary Details
    OPEN
    Title: Low continuation of antipsychotic therapy in Parkinson disease – intolerance, ineffectiveness, or inertia?
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-021-02265-x
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202114022
    Citation Count: 248
  • Summary Details
    OPEN
    Title: Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up study
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18538
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Genome-wide Analysis of Motor Progression in Parkinson Disease
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000200092
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcab109
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Interplay between tau and α‐synuclein liquid–liquid phase separation
    Journal Name: Protein Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/pro.4025
    Citation Count: 107
  • Summary Details
    OPEN
    Title: Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00561-6
    Citation Count: 74
  • Summary Details
    OPEN
    Title: Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00174-x
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Machine learning-based prediction of longitudinal cognitive decline in early Parkinson’s disease using multimodal features
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-37644-6
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Posterior Cortical Cognitive Deficits Are Associated With Structural Brain Alterations in Mild Cognitive Impairment in Parkinson’s Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2021.668559
    Citation Count: 31
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.